Injective tokenizes Ethereum asset reserve company SharpLink, and SBET can also be used on the chain to generate income

Injective Focuses on Financial Public Chain, Invited to David Sacks' Dinner

Injective (ticker INJ) is a blockchain designed for finance, with investors including Pantera Capital, Jump Crypto, YZi Labs, CMS Holdings, and notable billionaire Mark Cuban. As a US-made public chain, Injective was also invited to the crypto mogul David Sacks' dinner early this year, viewed as successfully breaking into the North American core circle.

(The Biggest Beneficiary of Trump's Crypto-Friendly Stance? Reviewing the Guest List of the Crypto Mogul's Dinner and US Chains)

NASDAQ-Listed Company SharpLink's Reserves Exceed Ethereum Foundation

SharpLink Gaming is a NASDAQ-listed gaming entertainment company (NASDAQ ticker SBET), drawing high market attention by announcing Ethereum as its capital operation strategy.

The company raised $425 million through a Private Investment in Public Equity (PIPE) model from institutions including ConsenSys, Galaxy Digital, and Pantera Capital, to be used for establishing Ethereum reserves. Ethereum co-founder and Metamask parent company ConsenSys CEO Joseph Lubin also joined SharpLink as chairman.

Injective Will Bring Ethereum Reserve Company SBET On-Chain

Injective recently announced launching a new asset framework iAssets and tokenizing SharpLink (SBET) on-chain. Injective stated this is the first on-chain digital asset treasury (DAT), transforming SBET's static corporate Ethereum reserves into an active, revenue-generating on-chain tool.

Injective's move is more than just tokenizing stocks. By combining its financial attributes, stock tokens can be used in DeFi to generate revenue. SharpLink is just the first step, and we might expect more stock and asset reserve company stocks to go on-chain.

Matt Sheffield, trading director at institutional-grade crypto broker FalconX, stated that the digital asset treasury opens new doors for institutional and retail investors, enabling them to enter the crypto market in a more structured and transparent way. The core value is to enable token-priced investments with potential to increase returns. The on-chain product tracking SBET launched by Injective marks an important milestone in bringing public market capital efficiency into DeFi infrastructure in a composable and transparent manner.